A pilot randomised placebo-controlled trial of cannabidiol to reduce severe behavioural problems in children and adolescents with intellectual disability

Key Findings:  The goal of this pilot study was to assess the feasibility of conducting a randomized controlled trial of cannabidiol in treating children with severe behavioral and intellectual disabilities. Overall the efficacy signal favored active drug.

Type of Study:  Double Blind Clinical Trial

Study Sample Size:  8

Study Result:  Positive

Study Location(s):  Australia

Year of Pub:  2021

Cannabinoids Studied:  Cannabidiol (CBD)

Phytocannabinoid Source:  Cannabis Flower derived

Chemotype:  Chemotype III

Dosage: Cannabidiol (20-1000 mg/kg/day)

Link to study